Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 1B1 (CYP1B1) is a heme-containing monooxygenase enzyme involved in the metabolism of various endogenous and exogenous compounds. It is predominantly expressed in extrahepatic tissues and plays a role in developmental processes, drug metabolism, and the synthesis/breakdown of lipids. CYP1B1 is implicated in diseases such as primary congenital glaucoma, cancer, obesity, hypertension, and atherosclerosis, making it a potential therapeutic target.
Selective inhibition or modulation of CYP1B1 activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 1B1 (CYP1B1).